ADAMTS13 and thrombotic thrombocytopenic purpura: Differentiation between congenital and acquired TTP is needed, through measurement of ADAMTS13 activity and autoantibodies, since use of immunosuppressive therapy is critical in cases of acquired TTP but is unnecessary in cases of congenital TTP.8